Aion Therapeutic
CompanyScienceThe AIResourcesPressInvestors

Press Releases

July 14, 2021

Aion Therapeutic’s Dr. De La Haye to Speak at the CanEx Psychedelics Summit

Read More

June 11, 2021

Aion Therapeutic Announces Closing of Non-Brokered Private Placement

Read More

May 18, 2021

Combined Apollon and Aion Formulations Kill Breast Cancer Cells Through Multiple Pathways

Read More

April 21, 2021

Aion Therapeutic’s Proprietary Mushroom Preparations Shown Effective in Killing Breast Can...

Read More

April 12, 2021

Aion Therapeutic Engages KCSA Strategic Communications as Corporate Communications Counsel

Read More

March 11, 2021

Aion Therapeutic Files 4 New Patent Applications (Including for the Treatment of Human Can...

Read More

February 23, 2021

Aion Therapeutic Opening the First International Treatment Center for Psychedelic Psychiat...

Read More

October 31, 2020

Aion Therapeutic Amends Convertible Debentures

Read More

October 21, 2020

Aion Therapeutic Names James W.G. Thompson, Ph.D. as President

Read More

Contact Us

45 Sheppard Avenue East, Suite 703, Toronto, ON, M2N 5W9

info@aiontherapeutic.com

Sign up for News & Investor Deck

Website by Web Disco Digital